Site icon pharmaceutical daily

City of Vacaville Approves Axiom Point, A New 375,000 SF Biomanufacturing Campus

Transwestern Project Expected to Attract Life Sciences Jobs to Area
Axiom Point Project Site

Map of Vacaville identified the project location for Axiom Point, a 22 acre vacant parcel located at the southeast end of Horse Creek Drive and west of Interstate 80.

Rendering of Axiom Point

Axiom Pointe Site Entry POV

VACAVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) — Transwestern Ventures (TWV), in partnership with Transwestern Real Estate Services (TRS), announces that the City of Vacaville’s Planning Commission has approved plans to develop Axiom Point, a 375,000-square-foot, state-of-the-art biomanufacturing campus. The new development will be located on 22.4 acres in Vaca Valley Business Park at the interchange of I-80 and I-505. Axiom Point is the first life science campus to take advantage of the City’s Biotechnology and Advanced Manufacturing Initiative, which boasts a Biotechnology Fast-Track Program committing the City to processing Planning entitlements in 100 days or less. “Vacaville has the land, infrastructure, and workforce that the biotechnology industry needs to grow, along with a long-standing commitment to a streamlined and frictionless process,” said City of Vacaville Mayor Ron Rowlett. “We are building on our proven success with the industry to secure Vacaville’s continued leadership as a biomanufacturing center going forward, and are fortunate that Transwestern sees the potential and value to investing in Vacaville. We look forward to the project getting underway!” A development of Transwestern Ventures, Axiom Point will deliver in two phases, the first comprising 252,000 square feet and the second comprising 123,000 square feet. Designed for maximum flexibility, the project is ideal for occupier needs including biomanufacturing, laboratory research and development, medical device manufacturing, food science, agricultural technology and healthcare. “We are excited to move forward with Axiom Point,” said Transwestern Managing Director Ken Meyersieck, who, along with Laboratory + Life Sciences experts Peter Conte and Andrew Wheeler, is handling leasing for the project. “The City of Vacaville has been a tremendous partner, providing excellent guidance and moving nimbly to approve the project. We are proud to offer this dynamic biomanufacturing campus in a region known for extraordinary talent and innovation.” “Transwestern formally submitted our application in early September and we were approved by the Planning Commission less than 90 days later,” said Fred Knapp, Managing Partner of Transwestern Ventures. “That very impressive turnaround is a testament to the focus and commitment by the City of Vacaville to make biomanufacturing a cornerstone of its economic development plan.” Vacaville is situated along I-80, the main thoroughfare between the state capital and the Bay Area. Its centralized proximity to San Francisco, Sacramento and the University of California’s Berkeley and Davis campuses provides access to top talent across the life sciences and advanced manufacturing sectors. Additionally, Solano Community College’s Vacaville campus sits adjacent to the Vaca Valley Business Park and has distinguished itself through the offering of two biomanufacturing baccalaureate programs. Vacaville is also home to the California Biomanufacturing Center Inc., a nonprofit dedicated to accelerating biomanufacturing growth. Due to its prime location, Vaca Valley Business Park has become home to life sciences companies such as Genentech, Johnson & Johnson, RxDNova, Agenus and Polaris. Per Transwestern research, there are approximately 39.1 million square feet of existing biomanufacturing space across the four major life science markets of Boston, San Francisco, San Diego and Raleigh/Durham, with an average building age of 34 years. Of that space, only 3.4 percent is currently available, underscoring the need for highly efficient, state-of-the-art biomanufacturing space through a project such as Axiom Point. The California-based project team includes DGA, a firm specializing in the design of technical facilities, including life sciences projects, and DPR Construction, the general contractor. Renderings available for download here. About Transwestern VenturesTranswestern Ventures (TWV) creates value for investors by sourcing and executing real estate investments across all property sectors nationwide. As the opportunistic investment arm of the Transwestern family of companies, Ventures works synergistically with the firm’s services, development and investment management businesses, bringing capital, financial engineering and operational expertise to undervalued or undermanaged properties, enterprises and unique investment opportunities. About Transwestern Real Estate ServicesTranswestern Real Estate Services (TRS) adds value for investors, owners and occupiers of all commercial property types through a comprehensive perspective and by providing solutions grounded in sound market intelligence. Part of the Transwestern companies, the firm applies a consultative approach to Agency Leasing, Asset Services, Tenant Advisory + Workplace Solutions, Capital Markets, and Research & Investment Analytics. About TranswesternThe privately held Transwestern companies have been delivering a higher level of personalized service and innovative real estate solutions since 1978. Through an integrated, customized approach that begins with good ideas, the firm drives value for clients across commercial real estate services, development, investment management, and opportunistic endeavors for high-net-worth investors. Operating from 33 U.S. offices, Transwestern extends its platform capabilities globally through strategic alliance partners whose unique geographic, cultural, and business expertise fuels creative solutions. Learn more at transwestern.com and @Transwestern. Media Contact:Molly McMurtry 713.231.1571 molly.mcmurtry@transwestern.comtwmediarelations@transwestern.com Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/63e56d3c-5a2d-4da2-a76c-d56d46a81215 https://www.globenewswire.com/NewsRoom/AttachmentNg/d1ee2ab9-57a1-4149-b5b9-269fde5754f2

Exit mobile version